Synthesis and antidiabetic evaluation of benzenesulfonamide derivatives

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 2, 2013, Pages 325-330

  Hosseinzadeh, Nouraddin ^a   Seraj, Soodeh ^b   Bakhshi Dezffoli, Mohamad Ebrahim ^a   Hasani, Mohammad ^c   Khoshneviszadeh, Mehdi ^a   Fallah Bonekohal, Saeed ^a   Abdollahi, Mohammad ^a   Foroumadi, Alireza ^d   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antidiabetic activity; Benzenesulfonamides; Diabetes mellitus; Thiazole

Indexed keywords

2,4,5 TRICHLORO N 4 (4 METHOXYPHENYL) THIAZOL 2 YL BENZENESULFONAMIDE; 2,5 DICHLORO N 4 (4 METHOXYPHENYL) THIAZOL 2 YL BENZENESULFONAMIDE; 4 (4 CHLOROPHENYL) THIAZOL 2 AMINE; 4 (4 METHOXYPHENYL) THIAZOL 2 AMINE; 4 BROMO N 4 (4 METHOXYPHENYL) THIAZOL 2 YL BENZENESULFONAMIDE; 4 CHLORO N 4 (4 METHOXYPHENYL) THIAZOL 2 YL 4 BENZENESULFONAMIDE; 4 METHOXY N 4 (4 METHOXYPHENYL) THIAZOL 2 YL BENZENESULFONAMIDE; ALLOXAN; BENZENESULFONAMIDE DERIVATIVE; GLIBENCLAMIDE; N 4 (4 CHLOROPHENYL) THIAZOL 2 YL 4 METHYLBENZENESULFONAMIDE; N 4 (4 CHLOROPHENYL) THIAZOL 2 YL BENZENESULFONAMIDE; N 4 (4 METHOXYPHENYL) THIAZOL 2 YL BENZENESULFONAMIDE; N 4 (4 METHOXYPHENYL) THIAZOL 2 YL) 4 METHYLBENZENESULFONAMIDE; STREPTOZOCIN; THIAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

EID: 84878907237     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chang LS, Li BC, Qin N, Jin MN and Duan HQ. Synthesis and Antidiabetic Activity of 5,7-Dihydroxyflavonoids and Analogs. Chem. Biodivers. (2012) 9: 162-169.
2. Dixit M, Tripathi BK, Tamrakar AK, Srivastava AK, Kumar B and Goel A. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors. Bioorg. Med. Chem. (2007) 15: 727-734.
3. Yue EW, Wayland B, Douty B, Crawley ML, McLaughlin E, Takvorian A, Wasserman Z, Bower MJ, Wei M, Li YL, Ala PJ, Gonneville L, Wynn R, Burn TC, Liu PCC and Combs AP. Isothiazolidinone heterocycles as inhibitors of protein phosphatases: synthesis and structure-activity relationships of a peptidescaffold. Bioorg. Med. Chem. (2006) 14: 5833-5849.
4. Zhu Y, Zhang Y, Liu Y, Chu H and Duan H. Synthesis and Biological Activity of trans-Tiliroside Derivatives as Potent Anti-Diabetic Agents. Molecules (2010) 15: 9174-9183.
5. Carrington AL and Litchfield JE. glycation in the pathogenesis of diabetic neuropathy: a critical review for the end of the twentieth century. Diabetes Rev. (1999) 7: 275-299.
6. Sheet M J and King G L. Molecular understanding of hyperglycemia>s adverse effects for diabetic complications. J. Am. Med. Assoc. (2002) 288: 2579-2588.
7. Kamaeswara R B, Giri R, Kesavulu M M and Apparao C. Effect of oral administration of bark extracts of Pterocarpus santalinus L. on blood glucose level in experimental animals. J. Ethnopharmacol (2001) 74: 69-74.
8. Mariappan G, Saha B P, Datta S, Kumar D and Haldar PK. Design, synthesis and antidiabetic evaluation of oxazolone derivatives. ChemInform. (2011) 123: 335-341.
9. Stokstad ELR and Jukes TH. Sulfonamides and folic acid antagonists: a historical review. J. Nutr. (1987) 117: 1335-1341.
10. Hong YL, Hossler PA, Calhoun DH and Meshnic SR. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob. AgentsChemother. (1995) 39: 1756-1763.
11. Nalam MNL, Peeters A, Jonckers T H M, Dierynck I and Schiffer CA. Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease. J. Virol. (2007) 81: 9512-9518.
12. Mirian M, Zarghi A, Sadeghi S, Tabaraki P, Tavallaee M, Dadrass O and Sadeghi-aliabadi H. Synthesis and Cytotoxic Evaluation of Some Novel Sulfonamide Derivatives Against a Few Human Cancer Cells. Iranian J. Pharm. Res. (2011) 10:741-748.
13. Moreno-Diaz H, Villalobos-Molina R, Ortiz-Andrade R, Diaz-Coutino D, Medina-Franco J L, Webster SP, Binnie M, Estrada-Soto S, Ibarra-Barajas M, Leon-Rivera I and Navarrete-Vazquez G. Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl) benzenesulfonamides. Bioorg. Med. Chem. Lett. (2008) 18: 2871-2877.
14. Link JT, Sorensen BK, Patel J, Arendsen D, Li G, Swanson S, Nguyen B, Emery M, Grynfarb M and Goos-Nilsson A. Optimization and metabolic stabilization of a class of nonsteroidal glucocorticoid modulators. Bioorg. Med. Chem. Lett. (2004) 14: 4169-4172.
15. Fallah-Tafti A, Foroumadi A, Tiwari R, Shirazi AN, Hangauer DG, Bu Y, Akbarzadeh T, Parang K and Shafiee A. Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. Eur. J. Med. Chem. (2011) 46: 4853-4858.
16. Nakhjiri M, Safavi M, Alipour E, Emami S, Atash AF, Jafari-Zavareh M, Ardestani SK, Khoshneviszadeh M, Foroumadi A and Shafiee A. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Eur. J. Med. Chem. (2012) 50:113-123.
17. Rastkari N, Abdollahi M, Ahmadkhaniha R and Shafiee A. Syntheses and biological activities of benzimidazolo [2,1-b] benzo[e]thiazepin-5(10H)-ones. Arch. Pharm (Weinheim). (2008) 341: 49-54.
18. Faizi M, Sheikhha M, Ahangar N, Tabatabaei Ghomi H, Shafaghi B, Shafiee A and Tabatabai SA. Design, synthesis and pharmacological evaluation of novel 2-[2-(2-Chlorophenoxy) phenyl]-1, 3,4-oxadiazole Derivatives as Benzodiazepine Receptor Agonists. Iranian J. Pharm. Res. (2012) 11: 83-90.
19. Shamsa F, Foroumadi A, Shamsa H, Samadi N, Faramarzi MA and Shafiee A. Synthesis and in-vitro antibacterial activities of acetylanthracene and acetylphenanthrene derivatives of some fluoroquinolones. Iranian J. Pharm. Res. (2011) 10:225-231.
20. Roever S, Cesura A M, Huguenin P, Kettler R and Szente A. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl) benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase. J. Med. Chem. (1997) 40: 4378-4385.